United States: Updates On Aflibercept BPCIA Litigation - Goodwin Procter LLP

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed a motion seeking to establish a multi-district litigation ("MDL")...